Clinical Outcomes of Stereotactic Ablative Radiotherapy for All Stages of Non-Small Cell Lung Cancer; Definitive versus Consolidative

Background and Objectives: Stereotactic ablative radiotherapy (SABR) is not confined to early stage non-small cell lung cancer (NSCLC) and has a potential role in stage IV disease. We aimed to evaluate the effect of SABR on local control rates and survival outcomes in patients with all stages of NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hakyoung, Kim, Sun Myung, Yang, Dae Sik, Lee, Kyung Hwa, Kim, Young Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506516/
https://www.ncbi.nlm.nih.gov/pubmed/36143981
http://dx.doi.org/10.3390/medicina58091304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506516/
https://www.ncbi.nlm.nih.gov/pubmed/36143981
http://dx.doi.org/10.3390/medicina58091304

Ejemplares similares